Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variants increase the risk of aggressive prostate cancer.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Androgen use may increase the risk of stroke, but more research is needed.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Ischemia-modified albumin can help diagnose ischemic conditions early, but better detection methods are needed.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Wearing a toupee makes men seem more attractive and slightly healthier, but doesn't change how confident they appear.

Alopecia Areata causes significant structural and compositional changes in hair.

Photobiomodulation may improve certain health conditions, but more high-quality research is needed.

Polysaccharide-based nanofibers are promising for better wound healing.

PHAs are promising biodegradable materials for medical and dental uses.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Regenerative therapies show promise for hair regrowth, but more research and standardization are needed.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

Hair transplants can work for stable cicatricial alopecia, but success varies by condition.

3D bioprinting is advancing in plastic and reconstructive surgery, especially for creating tissues and improving surgical planning, but faces challenges like vascularization and material development.

The conclusions are: fecal short-chain fatty acids may help prevent cancer, fiber intake can reduce obesity, weight loss is hard for obese people, low BMI cancer patients are more prone to chemotherapy side effects, intermittent fasting benefits gut health, cherry laurel has health benefits in rats, certain gene variations can increase stress in hair loss patients, fecal acids can affect blood sugar levels, cold agglutinin can affect blood test results in autoimmune patients, and people with Crohn's disease have higher levels of a certain chemical in their blood.

The zinc-coordinated nanogel therapy speeds up wound healing after pancreas surgery by balancing metabolism and fighting bacteria.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Women with PCOS may be at higher risk for severe COVID-19.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Understanding sex and gender differences can improve personalized dermatology care.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.